Qingqing Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qingqing Zheng has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Le Zhang
Department of Neonatology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China; Clinical Research Center, Affiliated Children's Hospital of Jiangnan University, Wuxi Children's Hospital, Jiangsu Provincial Industrial Technology Engineering Center for Pediatric Metabolic Disease Prevention and Control, Wuxi Key Laboratory of Genetic and Metabolic Diseases in Children, Wuxi 214023, Jiangsu, China
2 shared publications Yueju Wang
Clinical Research Center, Affiliated Children's Hospital of Jiangnan University, Wuxi Children's Hospital, Jiangsu Provincial Industrial Technology Engineering Center for Pediatric Metabolic Disease Prevention and Control, Wuxi Key Laboratory of Genetic and Metabolic Diseases in Children, Wuxi 214023, Jiangsu, China
2 shared publicationsBen Liu
Pediatric Intensive Care Unit, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
1 shared publicationCai Tang
Department of Pediatric Laboratory, Affiliated Children’s Hospital of Jiangnan University (Wuxi Children’s Hospital), Wuxi, People’s Republic of China
1 shared publicationHaoyang Zhang
Department of Pediatric Laboratory, Affiliated Children’s Hospital of Jiangnan University (Wuxi Children’s Hospital), Wuxi, People’s Republic of China
1 shared publicationJingzi Zhong
Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, China
1 shared publication
Latest Publications
- 8 September 2026
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 91, 723-731
Assessment of health literacy among family caregivers of school-aged children with metabolic dysfunction associated steatotic liver disease
- 8 September 2026
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 91, 723-731
Assessment of health literacy among family caregivers of school-aged children with metabolic dysfunction associated steatotic liver disease
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-15
Determinants of Liver Steatosis Progression in Chinese Children: A Prospective Cohort Study
Background: Liver steatosis in children can be non-invasively assessed by the controlled attenuation parameter (CAP) derived from transient elastography. This study aimed to identify determinants of longitudinal changes in liver steatosis in a Chinese pediatric population. Methods: We established a prospective cohort in Wuxi, China, to investigate risk factors of fatty liver among school-aged children. A total of 1498 children aged 6 to 13 years were enrolled in 2023 and 1195 children completed follow-up assessments in 2024. Biomarkers based on blood, urine, and body composition were measured. The progression of liver steatosis was evaluated using CAP values. Regression analyses were conducted identify determinants of both longitudinal changes in CAP and the progression of liver steatosis. Results: The average CAP of the participants in 2023 was 193.5 dB/m, and in 2024 it was 189.0 dB/m. During the one-year follow-up period, 68 children developed new liver steatosis. Regression analyses revealed 10 biomarkers significantly associated with changes in CAP, which were further categorized into two distinct clusters characterized primarily by metabolic and inflammatory processes. Additionally, the ratio of neutrophils to albumin constituted a separate subgroup. For liver steatosis progression, stepwise logistic regression identified four independent determinants: sex, BMI z-score, lymphocyte count, and trunk body fat mass, and demonstrated good discriminatory power (AUC = 0.80). Conclusion: Several inflammatory and body composition markers were significantly associated with the progression of liver steatosis in Chinese children. These findings underscore the roles of inflammation and fat distribution in the early development of fatty liver disease, which may inform screening strategies for school-aged children.
- 1 April 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-15
Open AccessDeterminants of Liver Steatosis Progression in Chinese Children: A Prospective Cohort Study
Background: Liver steatosis in children can be non-invasively assessed by the controlled attenuation parameter (CAP) derived from transient elastography. This study aimed to identify determinants of longitudinal changes in liver steatosis in a Chinese pediatric population. Methods: We established a prospective cohort in Wuxi, China, to investigate risk factors of fatty liver among school-aged children. A total of 1498 children aged 6 to 13 years were enrolled in 2023 and 1195 children completed follow-up assessments in 2024. Biomarkers based on blood, urine, and body composition were measured. The progression of liver steatosis was evaluated using CAP values. Regression analyses were conducted identify determinants of both longitudinal changes in CAP and the progression of liver steatosis. Results: The average CAP of the participants in 2023 was 193.5 dB/m, and in 2024 it was 189.0 dB/m. During the one-year follow-up period, 68 children developed new liver steatosis. Regression analyses revealed 10 biomarkers significantly associated with changes in CAP, which were further categorized into two distinct clusters characterized primarily by metabolic and inflammatory processes. Additionally, the ratio of neutrophils to albumin constituted a separate subgroup. For liver steatosis progression, stepwise logistic regression identified four independent determinants: sex, BMI z-score, lymphocyte count, and trunk body fat mass, and demonstrated good discriminatory power (AUC = 0.80). Conclusion: Several inflammatory and body composition markers were significantly associated with the progression of liver steatosis in Chinese children. These findings underscore the roles of inflammation and fat distribution in the early development of fatty liver disease, which may inform screening strategies for school-aged children.